🇺🇸 FDA
Patent

US 9493552

Therapeutic biologic for treatment of hepatocellular carcinoma

granted A61KA61K2039/505A61K47/65

Quick answer

US patent 9493552 (Therapeutic biologic for treatment of hepatocellular carcinoma) held by China Synthetic Rubber Corporation expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
China Synthetic Rubber Corporation
Grant date
Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K2039/505, A61K47/65, A61K47/6811, A61K47/6849